Retatrutide is an innovative research peptide currently under investigation as a potential treatment for obesity and metabolic disorders. This triagonist peptide simultaneously activates receptors for three key metabolic hormones: glucagon, glucose-dependent insulinotropic polypeptide (GIP), and glucagon-like peptide-1 (GLP-1).
Our retatrutide research peptide for sale is manufactured under strict quality control standards, with HPLC purity exceeding 99.88%. The white freeze-dried powder form ensures stability and ease of reconstitution for research purposes.
Available in various quantities from 5mg to 60mg, this peptide is ideal for laboratory research investigating metabolic pathways and potential therapeutic applications. The product is supplied in sterile vials with proper labeling for research identification.
Important Note: This product is for research use only. Not for human or veterinary use. Researchers should handle all peptides with appropriate laboratory safety protocols.